Document Detail


Antidepressant use during pregnancy: the benefit-risk ratio.
MedLine Citation:
PMID:  22425404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Antidepressants are used commonly in pregnancy. Physicians who provide health care for pregnant women with depression must balance maternal well-being with potential fetal risks of these medications. Over the last decade, scores of original and review articles have discussed whether selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors possess risks to the fetus; however, very little has been done to integrate these potential risks, if they exist, into an overall context of a benefit:risk ratio. This review aims at presenting an updated analysis of fetal and maternal exposure to selective serotonin or norepinephrine reuptake inhibitors to allow an evidence-based benefit:risk ratio. When a psychiatric condition necessitates pharmacotherapy, the benefits of such therapy far outweigh the potential minimal risks of cardiac malformations, primary pulmonary hypertension of the newborn infant, or poor neonatal adaptation syndrome.
Authors:
Gideon Koren; Hedvig Nordeng
Related Documents :
3939974 - Is the sex ratio at birth affected by immune selection?
22914234 - Rupture of an unscarred uterus diagnosed in the puerperium: a rare occurrence.
8117824 - Developmental changes in paramesonephric and mesonephric ducts and anogenital distance ...
259044 - When a conception fails to become a pregnancy.
16620934 - Long-term cryopreservation of mouse sperm.
17290274 - Evaluation of stox1 as a preeclampsia candidate gene in a population-wide sample.
Publication Detail:
Type:  Journal Article; Review     Date:  2012-02-21
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  207     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-09-03     Completed Date:  2012-11-13     Revised Date:  2012-12-21    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  157-63     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 Mosby, Inc. All rights reserved.
Affiliation:
Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada. gkoren@sickkids.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology
Antidepressive Agents / adverse effects,  therapeutic use*
Depression / drug therapy*
Female
Fetal Diseases / chemically induced
Humans
Odds Ratio
Pregnancy
Pregnancy Complications / drug therapy*
Risk Assessment
Chemical
Reg. No./Substance:
0/Antidepressive Agents
Comments/Corrections
Comment In:
Am J Obstet Gynecol. 2012 Nov;207(5):e10-1; author reply e11   [PMID:  22917485 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictors of long-acting reversible contraception use among unmarried young adults.
Next Document:  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress i...